Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from telogen effluvium can cause mental health issues and lower life quality, needing both medical and emotional support.

Claudin-1 and Claudin-3 are crucial for keeping hair follicle structure and preventing a type of hair loss called telogen effluvium.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Long COVID causes various long-term health issues and needs better awareness and treatment.

Deep skin fibroblasts help recruit immune cells for better wound healing.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Fatigue is the most common symptom in both ongoing symptomatic COVID-19 and post-COVID-19 syndrome.

The Asian herbal mix with Houttuynia cordata, Perilla frutescens, and green tea helped grow hair in mice.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Low ferritin, vitamin D deficiency, and thyroid problems may contribute to hair loss in some hospital patients in Western Saudi Arabia.

COVID-19 may cause hair loss by affecting hair follicles.

A woman survived a massive lithium overdose that caused a form of hair loss.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Telogen effluvium patients have a worse quality of life, but similar self-esteem compared to others.

MMP® with minoxidil may improve hair growth in chronic telogen effluvium.

A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Post-COVID-19 patients are at risk for hair loss.

COVID-19 infection is highly related to increased hair loss, especially in women.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

Low levels of iron and vitamin D might be linked to chronic hair loss in women.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

People with chronic hair shedding had much lower vitamin D levels compared to healthy people.